Request a DemoQUASI-DRUG topicals in Japan fall between cosmetics and pharmaceuticals, with a wide range of vague concepts and classifications, and the regulations and compliance requirements for QUASI-DRUG topicals are also complex. In recent years, incidents such as mass skin inflammation caused by skin lightening products, adjustments in labeling and efficacy requirements for QUASI-DRUG products, and stricter scrutiny of ingredients have required companies to make timely strategic adjustments to ensure sustainability and competitiveness.
To help cosmetic companies address these challenges, ChemLinked is hosting an exclusive webinar titled "Ensuring Compliance: A Guide to Japan's Quasi-drug Regulations." By attending this seminar, participants will be able to gain an in-depth understanding of the Japanese cosmetic regulatory system, product registration procedures for QUASI-DRUG, product compliance points, and labeling considerations for QUASI-DRUG.
In this webinar, Chemlinked has invited Mr. Yuan Tiangu, a professional regulatory expert and market analyst, to discuss the core compliance issues of Japan's QUASI-DRUG products through fascinating case studies and practical applications. Experts from ChemLinked will offer the same content in Chinese to cater to attendees from different language backgrounds. Through this webinar, we will share with you the latest regulatory requirements, innovative compliance strategies and emerging market trends, and provide you with practical solutions to help you better understand and address compliance challenges.
Notes:
Please feel free to send us questions before, during or after the webinar;
The webinar livestreaming is freely available to all users. You are welcome to register for and participate in the webinar.
Kindly be aware that the access to the slides, recording, and Q&A collection is limited to ChemLinked premium members only [Upgrade now].
